Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M81,848Revenue $M16,385Net Margin (%)15.6Z-Score5.1
Enterprise Value $M82,495EPS $1.5Operating Margin %18.9F-Score5
P/E(ttm))28.5Cash Flow Per Share $2.8Pre-tax Margin (%)17.6Higher ROA y-yY
Price/Book5.310-y EBITDA Growth Rate %0.7Quick Ratio1.6Cash flow > EarningsY
Price/Sales5.05-y EBITDA Growth Rate %-13.3Current Ratio1.9Lower Leverage y-yN
Price/Cash Flow11.7y-y EBITDA Growth Rate %114ROA % (ttm)6.6Higher Current Ratio y-yY
Dividend Yield %2.9Insider Buy (3m)0ROE % (ttm)16.9Less Shares Outstanding y-yN
Payout Ratio %61.0Shares Outstanding M1,657ROI % (ttm)5.7Gross Margin Increase y-yN

Gurus Latest Trades with BMY

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMYRonald Muhlenkamp 2014-03-31 Buy 1.9%$48.54 - $56.61
($53.23)
$ 49.39-7%New holding, 212015 sh.212,015
BMYVanguard Health Care Fund 2014-03-31 Add0.73%$48.54 - $56.61
($53.21)
$ 49.39-7%Add 20.35%29,437,761
BMYRay Dalio 2014-03-31 Buy $48.54 - $56.61
($53.23)
$ 49.39-7%New holding, 4428 sh.4,428
BMYGeorge Soros 2014-03-31 Sold Out -0.05%$48.54 - $56.61
($53.23)
$ 49.39-7%Sold Out0
BMYJoel Greenblatt 2014-03-31 Sold Out -0.02%$48.54 - $56.61
($53.23)
$ 49.39-7%Sold Out0
BMYJoel Greenblatt 2013-12-31 Buy 0.02%$46.41 - $53.84
($50.96)
$ 49.39-3%New holding, 11679 sh.11,679
BMYVanguard Health Care Fund 2013-09-30 Add0.64%$41.32 - $47.53
($43.84)
$ 49.3913%Add 20.26%24,459,861
BMYJean-Marie Eveillard 2013-09-30 Reduce-0.01%$41.32 - $47.53
($43.84)
$ 49.3913%Reduce -75.17%16,520
BMYVanguard Health Care Fund 2013-06-30 Add0.39%$39.68 - $47.68
($43.41)
$ 49.3914%Add 13.32%20,338,461
BMYGeorge Soros 2013-06-30 Buy 0.05%$39.68 - $47.68
($43.41)
$ 49.3914%New holding, 100000 sh.100,000
BMYJean-Marie Eveillard 2013-06-30 Add0.01%$39.68 - $47.68
($43.41)
$ 49.3914%Add 302.66%66,520
BMYRay Dalio 2013-06-30 Sold Out -0.07%$39.68 - $47.68
($43.41)
$ 49.3914%Sold Out0
BMYPrem Watsa 2013-06-30 Sold Out -0.01%$39.68 - $47.68
($43.41)
$ 49.3914%Sold Out0
BMYVanguard Health Care Fund 2013-03-31 Add0.96%$32.59 - $41.19
($36.62)
$ 49.3935%Add 49.53%17,948,561
BMYRay Dalio 2013-03-31 Add0.05%$32.59 - $41.19
($36.62)
$ 49.3935%Add 267.87%181,140
BMYJohn Hussman 2013-03-31 Sold Out -0.64%$32.59 - $41.19
($36.62)
$ 49.3935%Sold Out0
BMYJames Barrow 2013-03-31 Sold Out -0.05%$32.59 - $41.19
($36.62)
$ 49.3935%Sold Out0
BMYJohn Hussman 2012-12-31 Reduce-0.2%$30.81 - $34.38
($32.89)
$ 49.3950%Reduce -25%750,000
BMYJames Barrow 2012-12-31 Reduce-0.02%$30.81 - $34.38
($32.89)
$ 49.3950%Reduce -22.36%795,409
BMYRay Dalio 2012-12-31 Reduce-0.01%$30.81 - $34.38
($32.89)
$ 49.3950%Reduce -21.64%49,240
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BMY Ronald Muhlenkamp 2014-03-31212,0150.011.9New Buy
BMY Ray Dalio 2014-03-314,42800New Buy
BMY Vanguard Health Care Fund 2014-03-3129,437,7611.784.3+20.35%
BMY Jean-Marie Eveillard 2014-03-3116,52000
BMY Dodge & Cox 2014-03-3179,12100-1%
BMY Mario Gabelli 2014-03-31686,7850.040.19-6.02%
BMY Joel Greenblatt 2014-03-31000Sold Out
BMY George Soros 2014-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


BMY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Caldarella Joseph CSVP & Controller 2014-03-13Sell9,137$55.2-10.4view
ANDREOTTI LAMBERTOCEO 2014-03-10Sell100,000$55.52-10.91view
Schmukler Louis SPres., Global Mfg. & Supply 2014-03-10Sell8,799$55.81-11.38view
CORNELIUS JAMES MDirector 2014-03-05Sell100,000$55.82-11.39view
Schmukler Louis SPres., Global Mfg. & Supply 2014-02-28Sell6,088$54.49-9.23view
Caforio GiovanniEVP & Chief Commercial Officer 2014-02-24Sell41,563$54.44-9.15view
Elicker John ESVP Pub Affairs & Inv Relation 2014-02-19Sell9,534$54.22-8.78view
Cuss Francis MEVP & CSO 2014-02-18Sell29,800$54.61-9.43view
LEUNG SANDRAGeneral Counsel & Secretary 2014-02-14Sell10,490$54.28-8.88view
Bancroft Charles AEVP & CFO 2014-02-14Sell52,963$54.35-9view

Press Releases about BMY :

Quarterly/Annual Reports about BMY:

News about BMY:

Articles On GuruFocus.com
UnitedHealth Group Up on Weak Day for the Dow Jul 17 2014 
Pharma Sector Stocks To Consider For Sustained Returns Jun 25 2014 
Johnson & Johnson (JNJ) Dividend Stock Analysis May 29 2014 
A Look at AstraZeneca’s New Drug on Diabetes May 22 2014 
Vanguard Health Care Fund's Top Quarterly Holdings Apr 30 2014 
Abbvie Inc. (ABBV) Dividend Stock Analysis Mar 21 2014 
Abbott Capturing Incremental Market Share Mar 18 2014 
Vanguard Health Care Fund’s Top Five Feb 10 2014 
Bristol-Myers: Don’t Let This One Get Away Jan 15 2014 
AstraZeneca: Time to Make a Bet? Steven Cohen Seems to Think It Is Jan 15 2014 


More From Other Websites
EMA recommends expanded indication for Baraclude Jul 25 2014
BioMed Realty And Bristol-Myers Squibb Sign Lease To Expand Relationship To 194,100 Square Feet At... Jul 24 2014
Bristol-Myers Squibb Company's (BMY) CEO Lamberto Andreotti Q2 2014 Results - Earnings Call... Jul 24 2014
BioMed Realty And Bristol-Myers Squibb Sign Lease To Expand Relationship To 194,100 Square Feet At... Jul 24 2014
Bristol-Myers (BMY) Beats on Q2 Earnings, Maintains Outlook Jul 24 2014
[video] Bristol-Myers Q2 Sales Fall, Will Focus on Cancer Drugs Jul 24 2014
Bristol-Myers profit tops forecasts, helped by newer drugs Jul 24 2014
[$$] Bristol-Myers Posts Lower Profit, Revenue Jul 24 2014
Bristol-Myers Squibb Reports Second Quarter 2014 Financial Results Jul 24 2014
Bristol-Myers says M&A would have to be good strategic fit Jul 24 2014
Bristol 2Q net drops on lower drug sales, charges Jul 24 2014
Bristol 2Q net drops on lower drug sales, charges Jul 24 2014
Bristol-Myers says guidance assumes R&D credit will be extended Jul 24 2014
Bristol-Myers Squibb Co Earnings Call scheduled for 10:30 am ET today Jul 24 2014
Stock Futures Steer Higher; Facebook, Skechers Nail Q2 Wins Jul 24 2014
Ford earnings, jobless claims to lift Wall Street Jul 24 2014
BRISTOL MYERS SQUIBB CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 24 2014
[video] Ford Beats, GM Stalls, Eli Lilly Reports & Jim Cramer's Bank Pick Jul 24 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide